 |
The Journal of Neuroscience, June 1, 2005, 25(22):5351-5355; doi:10.1523/JNEUROSCI.0855-05.2005
Previous Article | Next Article 
BRIEF COMMUNICATION
Impaired Motor Learning in Mice Expressing TorsinA with the DYT1 Dystonia Mutation
Nutan Sharma,1
Mark G. Baxter,2
Jeremy Petravicz,1
D. Cristopher Bragg,1
Alonna Schienda,1
David G. Standaert,1 and
Xandra O. Breakefield1
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, and 2Department of Experimental Psychology, Oxford University, Oxford OX1 3UD, United Kingdom
Primary early-onset generalized dystonia is an autosomal dominant disorder caused by a deletion ( GAG) in the DYT1 gene encoding torsinA. The gene defect has incomplete penetrance, with 30% of carriers developing clinically evident dystonia. We describe lines of transgenic mice that express either human mutant torsinA (hMT) or human wild-type (hWT) torsinA. All mice demonstrated moderately increased levels of torsinA in the brain by Western blot analysis and normal subcellular distribution of torsinA in neurons by confocal microscopy. No animals had dystonic features. However, mice overexpressing hMT, but not hWT, torsinA displayed a reduced ability to learn motor skills in an accelerating rotarod paradigm. This pattern resembles the impaired motor sequence learning demonstrated in human nonmanifesting carriers of the GAG mutation. Open-field testing showed no differences in spontaneous activity between transgenic mice and their nontransgenic littermates, indicating that mice overexpressing hMT torsinA did not develop overtly abnormal motor behavior. Together, these data suggest that these transgenic mice provide a useful model of the GAG carrier state that can be used to probe genetic and environmental factors that can trigger the dystonic state.
Key words: DYT1; transgenic mouse; motor learning; dystonia; TorsinA; nuclear envelope
Received Dec 11, 2004;
revised April 5, 2005;
accepted April 10, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
A. Granata, R. Watson, L. M. Collinson, G. Schiavo, and T. T. Warner
The Dystonia-associated Protein TorsinA Modulates Synaptic Vesicle Recycling
J. Biol. Chem.,
March 21, 2008;
283(12):
7568 - 7579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yokoi, M. T. Dang, S. Mitsui, J. Li, and Y. Li
Motor Deficits and Hyperactivity in Cerebral Cortex-specific Dyt1 Conditional Knockout Mice
J. Biochem.,
January 1, 2008;
143(1):
39 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yokoi, M. T. Dang, J. Li, and Y. Li
Myoclonus, Motor Deficits, Alterations in Emotional Responses and Monoamine Metabolism in {varepsilon}-Sarcoglycan Deficient Mice
J. Biochem.,
July 1, 2006;
140(1):
141 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kock, T. V. Naismith, H. E. Boston, L. J. Ozelius, D. P. Corey, X. O. Breakefield, and P. I. Hanson
Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier
Hum. Mol. Genet.,
April 15, 2006;
15(8):
1355 - 1364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gonzalez-Alegre, N. Bode, B. L. Davidson, and H. L. Paulson
Silencing Primary Dystonia: Lentiviral-Mediated RNA Interference Therapy for DYT1 Dystonia
J. Neurosci.,
November 9, 2005;
25(45):
10502 - 10509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meunier and M. Hallett
Endophenotyping: A window to the pathophysiology of dystonia
Neurology,
September 27, 2005;
65(6):
792 - 793.
[Full Text]
[PDF]
|
 |
|
|